Abstract:Abstract Background Estrogen receptors (ERs) are thought to play an important role in non-small cell lung cancer (NSCLC). However, the effect of ERs in NSCLC is still controversial and needs further investigation. A new consideration is that ERs may affect NSCLC progression through complicated molecular signaling networks rather than individual targets. Therefore, this study aims to explore the effect of ERs in NSCLC from the perspective of cancer systems biology. Methods The gene expression profile of NSCLC samples in TCGA dataset was analyzed by bioinformatics method. Variations of cell behaviors and protein expression were detected in vitro. The kinetic process of molecular signaling network was illustrated by a systemic computational model. At last, immunohistochemical (IHC) and survival analysis was applied to evaluate the clinical relevance and prognostic effect of key receptors in NSCLC. Results Bioinformatics analysis revealed that ERs might affect many cancer-related molecular events and pathways in NSCLC, particularly membrane receptor activation and signal transduction, which might ultimately lead to changes in cell behaviors. Experimental results confirmed that ERs could regulate cell behaviors including cell proliferation, apoptosis, invasion and migration; ERs also regulated the expression or activation of key members in membrane receptor signaling pathways such as epidermal growth factor receptor (EGFR), Notch1 and Glycogen synthase kinase-3β/β-Catenin (GSK3β/β-Catenin) pathways. Modeling results illustrated that the promotive effect of ERs in NSCLC was implemented by modulating the signaling network composed of EGFR, Notch1 and GSK3β/β-Catenin pathways; ERs maintained and enhanced the output of oncogenic signals by adding redundant and positive-feedback paths into the network. IHC results echoed that high expression of ERs, EGFR and Notch1 had a synergistic effect on poor prognosis of advanced NSCLC. Conclusions This study indicated that ERs were likely to promote NSCLC progression by modulating the integrated membrane receptor signaling network composed of EGFR, Notch1 and GSK3β/β-Catenin pathways and then affecting tumor cell behaviors. It also complemented the molecular mechanisms underlying the progression of NSCLC and provided new opportunities for optimizing therapeutic scheme of NSCLC.

Estrogen receptor beta promotes lung cancer invasion via increasing CXCR4 expression

Estrogen Promotes the Metastasis of Non‑small Cell Lung Cancer Via Estrogen Receptor Β by Upregulation of Toll‑like Receptor 4 and Activation of the Myd88/nf‑κb/mmp2 Pathway.

Estrogen promotes tumor metastasis via estrogen receptor beta-mediated regulation of matrix-metalloproteinase-2 in non-small cell lung cancer

Estrogen receptor β signaling regulates the progression of Chinese non-small cell lung cancer.

ERα-mediated Alterations in Circ_0023642 and Mir-490-5p Signaling Suppress Bladder Cancer Invasion

ERβ Promoted Invadopodia Formation‐mediated Non‐small Cell Lung Cancer Metastasis Via the ICAM1/p‐Src/p‐Cortactin Signaling Pathway

Estrogen receptors promote NSCLC progression by modulating the membrane receptor signaling network: a systems biology perspective

Silencing of circRPPH1 Inhibits the Progression of Non-Small-Cell Lung Cancer Through miR-326/ERBB4 Signal Axis

Exosomal ERBB2IP contributes to tumor growth via elevating PSAT1 expression in non‐small cell lung carcinoma

Hypoxia drives estrogen receptor β-mediated cell growth via transcription activation in non-small cell lung cancer

Circular RNA EPB41 expression predicts unfavorable prognoses in NSCLC by regulating miR-486-3p/eIF5A axis-mediated stemness

Oestrogen Receptor Β5 and Epidermal Growth Factor Receptor Synergistically Promote Lung Cancer Progression

Circular RNA circ-ERBB2 promotes HER2-positive breast cancer progression and metastasis via sponging miR-136-5p and miR-198

Estrogen Receptor Β Promotes Renal Cell Carcinoma Progression Via Regulating LncRNA HOTAIR-miR-138/200c/204/217 Associated CeRNA Network

CircN4BP2L2 promotes colorectal cancer growth and metastasis through regulation of the miR-340-5p/ CXCR4 axis

Androgen Receptor Suppresses Lung Cancer Invasion and Increases Cisplatin Response Via Decreasing TPD52 Expression.

circMET promotes NSCLC cell proliferation, metastasis, and immune evasion by regulating the miR-145-5p/CXCL3 axis.

CXCR4 is Involved in CD133-induced EMT in Non-Small Cell Lung Cancer.

Suppression of CX3CL1 by miR-497-5p inhibits cell growth and invasion through inactivating the ERK/AKT pathway in NSCLC cells

Circular RNA circ_001621 acts as a tumor promoter in lung cancer by regulating the miR-199a-3p/GREM1 axis

CXCR4 3′UTR functions as a ceRNA in promoting metastasis, proliferation and survival of MCF-7 cells by regulating miR-146a activity